Genomic Diagnostics
Revolutionizing Myotonic Dystrophy Type 1 Diagnostics with Nanopore Sequencing
Our latest analysis unveils RepeatLab, a groundbreaking Cas9-targeted nanopore sequencing workflow combined with an automated pipeline. This innovation delivers unprecedented resolution for repeat profiling, enabling accurate diagnosis and nuanced understanding of Myotonic Dystrophy Type 1 (DM1) with a rapid, cost-effective, and scalable approach.
Transforming Clinical Workflows & Patient Outcomes
RepeatLab significantly enhances diagnostic capabilities for challenging repeat expansion disorders. Its speed and accuracy unlock new possibilities for early intervention and personalized medicine.
0
Correlation with Traditional Assays
0
Minimum Reads for Accurate Detection
0
Target Gene Coverage per 100 Mb
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Methodology
Key Findings
Clinical Impact
RepeatLab integrates Cas9-targeted nanopore sequencing with an automated analysis pipeline to provide a comprehensive solution for repeat expansion disorder diagnostics. The workflow involves DNA extraction, library preparation (using Cas9 enrichment), nanopore sequencing, and data analysis via RepeatLab. This integrated approach ensures rapid and accurate results, typically within 24 hours.
The study validated RepeatLab's performance on DM1 samples, healthy controls, and cell lines. It significantly improved sensitivity and accuracy for large expansions, outperforming traditional methods like Southern blot and modified PCR. Key innovations include an alternative basecalling strategy for extended repeats and a robust repeat-length calling algorithm. The platform also automatically reports methylation near the DMPK repeat region, offering nuanced clinical insights.
RepeatLab provides a cost-effective diagnostic solution with a quick turnaround time, making it suitable for routine clinical applications. Its ability to profile large expansions and methylation status at single-allele resolution offers a more comprehensive understanding of DM1 pathogenesis, potentially aiding in prognosis and treatment strategies. The platform's accessibility and scalability further enhance its potential for widespread adoption in clinical settings.
Diagnosis Time Reduction
24 Hours Turnaround TimeEnterprise Process Flow
Sample Collection & DNA Extraction
→
Cas9-Targeted Library Preparation
→
Nanopore Sequencing
→
RepeatLab Analysis (Basecalling, Mapping, Repeat & Methylation Analysis)
→
Diagnostic Report Generation
| RepeatLab (Targeted Nanopore) | Traditional Methods (Southern Blot/PCR) | |
|---|---|---|
| Accuracy for Large Expansions |
|
|
| Turnaround Time |
|
|
| Methylation Profiling |
|
|
| Cost-Effectiveness |
|
|
DM1 Patient Cohort Validation
RepeatLab was successfully validated on 13 myotonic dystrophy type 1 (DM1) patient samples, 4 healthy controls, and 4 reference cell lines with known long expansions. The platform accurately estimated repeat lengths, assessed repeat structures, and profiled methylation patterns, providing a comprehensive view of the mutational landscape.
Key Outcome: Improved diagnostic yield and precision for DM1, especially for challenging large expansions.
Impact: Facilitates more nuanced clinical evaluations and potentially better-tailored patient management strategies by providing detailed genetic and epigenetic insights.
Calculate Your ROI with RepeatLab Integration
Estimate the potential time and cost savings for your enterprise by adopting our advanced diagnostic solutions. Tailor the inputs below to reflect your operational scale and see the impact.
Estimated Annual Savings
$0
Annual Hours Reclaimed
0
Your Phased Implementation Roadmap
A structured approach ensures a seamless integration of RepeatLab into your existing diagnostic infrastructure, maximizing adoption and impact.
Phase 1: Discovery & Customization
Initial consultation to understand your specific needs, existing infrastructure, and patient cohort characteristics. Customization of RepeatLab parameters and integration points.
Phase 2: Pilot Deployment & Validation
Deploy RepeatLab in a pilot environment with a subset of samples. Comprehensive validation against your internal standards and established methods, ensuring accuracy and reliability.
Phase 3: Full-Scale Integration & Training
Seamless integration with LIMS and reporting systems. Full training for your lab personnel and clinicians, ensuring proficiency and optimal utilization of the platform.
Phase 4: Ongoing Support & Optimization
Continuous technical support, software updates, and performance monitoring. Periodic reviews to identify further optimization opportunities and adapt to evolving diagnostic needs.
Ready to Transform Your Diagnostic Capabilities?
Partner with us to bring cutting-edge, high-resolution genomic diagnostics to your patients. Schedule a personalized consultation to see how RepeatLab can elevate your clinical practice.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat